(Q36662893)

15 August 2017

1 reference

title

Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments (English)

1 reference

15 August 2017

0 references

1 reference

Simona Guerzoni

4

0 references

Anna Ferrari

object named as

Anna Ferrari

5

0 references

author name string

Emilio Sternieri

1

1 reference

15 August 2017

Ciro Pio Rosario Coccia

2

1 reference

15 August 2017

Diego Pinetti

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Expert Opinion on Drug Metabolism & Toxicology

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

981-1007

1 reference

Predicting and preventing adverse drug reactions in the very old.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Antidepressant Drugs in the Elderly — Rôle of the Cytochrome P450 2D6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The International Classification of Headache Disorders: 2nd edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacologic management of acute attacks of migraine and prevention of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

French guidelines for the diagnosis and management of migraine in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clinical drug interactions in outpatients of a university hospital in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clinical pharmacokinetics of atenolol--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Metoprolol: a review of its use in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetics of long acting propranolol. Implications for therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Comparative pharmacokinetics of the newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Metabolism of tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clinical pharmacokinetics of clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The efficacy and safety of venlafaxine in the prophylaxis of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Drug interactions of clinical significance with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Selective serotonin reuptake inhibitors for late-life depression: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Venlafaxine. A review of its pharmacology and therapeutic potential in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clinically relevant drug interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Single-dose gabapentin pharmacokinetics and safety in healthy infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Therapeutic monitoring of the new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The clinical pharmacology of the new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Interactions between antiepileptic drugs and hormonal contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clinical pharmacokinetics of valproic acid--1988.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Drug treatment of epilepsy in elderly people: focus on valproic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Differential pharmacokinetics of lithium in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Irreversible coma, ergotamine, and ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Simultaneous determination of dexamethasone and 6 beta-hydroxydexamethasone in urine using solid-phase extraction and liquid chromatography: applications to in vivo measurement of cytochrome P450 3A4 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clinical pharmacokinetics of prednisone and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetics of the newer benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Drug interaction of tizanidine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Calcium antagonists. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetic interactions of drugs with St John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Safety and efficacy of eletriptan in the treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Cluster headache--clinical findings in 180 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Persistent cognitive deficits associated with lithium intoxication: a neuropsychological case description.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Performance of drug-drug interaction software for personal digital assistants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Elevation of thioridazine plasma levels by propranolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Digoxin-carvedilol interactions in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetics of the newer antidepressants: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Drug interaction between propafenone and metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Induction of propranolol metabolism by rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Effect of rifampicin on metoprolol and antipyrine kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Indinavir concentrations and St John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Verapamil toxicity resulting from a probable interaction with telithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Dose of midazolam should be reduced during diltiazem and verapamil treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Verapamil disposition--effects of sulphinpyrazone and cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The cardiac effects of therapeutic plasma concentrations of imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Nortriptyline toxicity secondary to interaction with bupropion sustained-release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Interaction between phenytoin and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Lamotrigine toxicity secondary to sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

New antiepileptic drugs: review on drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The effect of concurrent administration of sodium valproate on serum levels of primidone and its metabolite phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Ventricular fibrillation due to lithium withdrawal--an interaction with chlorpromazine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Mechanisms of lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Interaction between lithium salts and ispaghula husk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

The effect of intra-articular steroids on plasma salicylate concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Loss of therapeutic control in congenital adrenal hyperplasia due to interaction between dexamethasone and primidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Cyclosporine pharmacokinetic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Serotonin syndrome induced by fluvoxamine-lithium interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Interaction of metoprolol and fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

Drug-Induced Lithium Toxicity in the Elderly: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.6.981

21 January 2018

Identifiers

DOI

10.1517/17425255.2.6.981

1 reference

15 August 2017

1 reference